Axxcess Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Axxcess Wealth Management's RXRX Position: Q3 2026 in Review
Axxcess Wealth Management increased its Recursion Pharmaceuticals (RXRX) stake by 3.9% in Q3 2026, buying an estimated $5.18K and bringing the position to 40,297 shares worth $166K. The position accounts for 0.01% of the portfolio, ranked #948.
Axxcess Wealth Management first reported a position in RXRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $373K in Q1 2024. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Axxcess Wealth Management held 40,297 shares of Recursion Pharmaceuticals worth $166K as of Q3 2026.
- Axxcess Wealth Management bought 1,529 Recursion Pharmaceuticals shares in Q3 2026, an estimated $5.18K.
- Recursion Pharmaceuticals made up 0.01% of Axxcess Wealth Management's portfolio in Q3 2026, its #948 holding.
- Axxcess Wealth Management first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
- Axxcess Wealth Management's Recursion Pharmaceuticals position peaked at $373K in Q1 2024.
- 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Axxcess Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.